Sleep-walking with Zolpidem: Need for Continued Postmarketing Surveillance

The Food and Drug Administration issued a request to drug manufacturers to include these warnings in the labels of drugs approved for the treatment of insomnia in December 2006.

Saved in:
Bibliographic Details
Published in:Indian journal of psychological medicine 2015-10, Vol.37 (4), p.476-477
Main Authors: Sharma, Ajitha, Prakasha S., Rama
Format: Article
Language:English
Subjects:
GABA
Letter to Editor
Pharmaceutical industry
Side effects
Sleep
Sleepwalking
Surveillance
Citations: Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Food and Drug Administration issued a request to drug manufacturers to include these warnings in the labels of drugs approved for the treatment of insomnia in December 2006.
ISSN:0253-7176
0975-1564
DOI:10.4103/0253-7176.168617